论文部分内容阅读
为了解综合医院中1型糖尿病成年患者中药与西药使用种类及联合使用特征,以全国13家三级甲等医院信息系统(hospital information system,HIS)中2003年12月—2011年7月期间住院的4 602例1型糖尿病成年住院患者为研究对象,利用频数统计及关联规则方法分析其使用频率较高的西药和中药以及其联合使用情况。通过分析发现,临床治疗成年1型糖尿病患者时,西药以胰岛素为最多,共1 539例,占8.47%;中药以三七口服剂常见,共183例,占6.25%;中西药物常联合使用的有活血化瘀通脉舒络+血管扩张剂,支持度为45.93%,其次为活血化瘀通脉舒络+血管扩张剂+降糖药组合,支持度为45.50%;活血化瘀通脉舒络+血管扩张剂+营养剂组合支持度为36.29%。
In order to understand the types of Chinese medicine and western medicine used in adult patients with type 1 diabetes in general hospitals and the characteristics of combined use, this study was conducted in 13 hospital information systems (HIS) in China from December 2003 to July 2011 4 602 adults with inpatients with type 1 diabetes were enrolled in this study. The frequency of statistics and association rules were used to analyze the western and traditional Chinese medicines and their combined use. The analysis found that clinical treatment of adult patients with type 1 diabetes, Western medicine to insulin for the most, a total of 1 539 cases, accounting for 8.47%; Chinese medicine Sanqi oral common, a total of 183 cases, accounting for 6.25%; commonly used in traditional Chinese and Western medicine Blood circulation Tongmai Shulu + vasodilators, support for 45.93%, followed by blood circulation Tongmai Shulu + vasodilator + hypoglycemic combination, the support was 45.50%; blood circulation Tongmai Shu Network + vasodilator + nutrition support combination was 36.29%.